Please login to the form below

Not currently logged in
Email:
Password:

allergies

This page shows the latest allergies news and features for those working in and with pharma, biotech and healthcare.

Takeda gets FDA fast-track status for Zika vaccine

Takeda gets FDA fast-track status for Zika vaccine

Meanwhile, the National Institute of Allergy and Infectious Diseases (NIAID) in the US reported positive phase I results for a pair of DNA vaccine candidates in The Lancet last month, and

Latest news

More from news
Approximately 11 fully matching, plus 191 partially matching documents found.

Latest Intelligence

  • Asthma: beyond the blue and the brown Asthma: beyond the blue and the brown

    for prevention of cat and ragweed allergies.

  • Deal Watch July 2016 Deal Watch July 2016

    And Finally, Reality Bites. ALK-Abello has issued a press release announcing that Merck &Co has walked away from the deal agreed in 2007 (with Schering-Plough) for the allergy treatments ... Grastek and Ragwitek are sublingual allergy immunotherapy (SLIT)

  • Allergies and asthma Allergies and asthma

    Allergies and asthma. Reframing the conversation from disease burden to prevention and health promotion. ... The safest way to manage allergy symptoms is to tackle them before they set in.

  • Coming to an understanding Coming to an understanding

    We derived greater insight and intelligence.”. A similar process on the composition of an allergy panel for product testing had the physicians working in groups to devise their 'panel of the

  • Deal Watch February 2016 Deal Watch February 2016

    Annapurna brings a portfolio of four AAV-based gene therapy programmes at the preclinical stage for alpha-1 antitrypsin deficiency, hereditary angioedema, cardiomyopathy associated with Friedreich's ataxia and severe allergy.

More from intelligence
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest appointments

  • ALK-Abello appoints Søren Jelert as CFO ALK-Abello appoints Søren Jelert as CFO

    Dansih allergy immunotherapy company ALK-Abello has appointed Søren Jelert as its new chief financial officer, a role that sees him succeed Flemming Pederson at the pharmaceutical company. ... to become a truly global allergy company.”.

  • Cytovation expands management team Cytovation expands management team

    Grego is currently chief executive officer of Spire Bioventures, a global healthcare consultancy and mentoring service, and has previously held a number of management positions at Spanish allergy specialist Laboratorios LETI.

  • Lars Dreiøe joins Sobi in senior quality and compliance role Lars Dreiøe joins Sobi in senior quality and compliance role

    He will join the firm in January from Danish allergy vaccine company ALK Abelló, where he was international head of quality.

  • ARC names chairman and member of the board ARC names chairman and member of the board

    ARC is a privately held biopharma company developing desensitisation treatments for food allergies. ... Iwicki said: “ ARC is working to address a very compelling therapeutic area and provide an option to those dealing with food allergies.

  • Insmed appoints FDA's Dr Eugene Sullivan Insmed appoints FDA's Dr Eugene Sullivan

    He also spent a seven-year spell from 1999 at the FDA, where he held several positions, including deputy director of its Pulmonary and Allergy Products division.

More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics